Campath News
Most Popular Campath Story
Genzyme takes lead on Campath for MS
Genzyme is jumping into the multiple sclerosis market with both feet. The company has inked a deal with Bayer Healthcare for the right to transform the leukemia therapy Campath into a multiple Read more...
Latest Headlines
- November 9, 2010
- November 1, 2010
- October 25, 2010
- June 2, 2009
- April 1, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
